References - Contraception

1.              Committee opinion no. 607: Gynecologic concerns in children and adolescents with cancer. Obstetrics and gynecology 2014; 124(2 Pt 1): 403-8.
2.              WHO. Medical eligibility for contraceptive use. 4 th ed. Geneva; 2009.
3.              Patel A, Schwarz EB. Cancer and contraception. Release date May 2012. SFP Guideline #20121. Contraception 2012; 86(3): 191-8.
4.              Lindberg LD, Maddow-Zimet I. Consequences of sex education on teen and young adult sexual behaviors and outcomes. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2012; 51(4): 332-8.
5.              Kohler PK, Manhart LE, Lafferty WE. Abstinence-only and comprehensive sex education and the initiation of sexual activity and teen pregnancy. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2008; 42(4): 344-51.
6.              Mueller TE, Gavin LE, Kulkarni A. The association between sex education and youth's engagement in sexual intercourse, age at first intercourse, and birth control use at first sex. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2008; 42(1): 89-96.
7.              Committee Opinion No. 582: addressing health risks of noncoital sexual activity. Obstetrics and gynecology 2013; 122(6): 1378-82.
8.              Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar MS. Contraceptive Technology. 20 th ed: Ardent Media; 2011.
9.              ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstetrics and gynecology 2010; 115(1): 206-18.
10.           U S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control 2010; 59(RR-4): 1-86.
11.           Committee Opinion No. 602: Depot medroxyprogesterone acetate and bone effects. Obstetrics and gynecology 2014; 123(6): 1398-402.
12.           Lopez LM, Edelman A, Chen M, Otterness C, Trussell J, Helmerhorst FM. Progestin-only contraceptives: effects on weight. The Cochrane database of systematic reviews 2013; 7: CD008815.
13.           Bonny AE, Ziegler J, Harvey R, Debanne SM, Secic M, Cromer BA. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Archives of pediatrics & adolescent medicine 2006; 160(1): 40-5.
14.           Bonny AE, Lange HL, Rogers LK, Gothard DM, Reed MD. A pilot study of depot medroxyprogesterone acetate pharmacokinetics and weight gain in adolescent females. Contraception 2014; 89(5): 357-60.
15.           Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstetrics and gynecology 2012; 120(4): 983-8.
16.           Secura GM, Madden T, McNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. The New England journal of medicine 2014; 371(14): 1316-23.
17.           Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception 2011; 84(5): 493-8.
18.           Eisenberg D, McNicholas C, Peipert JF. Cost as a barrier to long-acting reversible contraceptive (LARC) use in adolescents. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2013; 52(4 Suppl): S59-63.
19.           Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM. Continuation of reversible contraception in teenagers and young women. Obstetrics and gynecology 2012; 120(6): 1298-305.
20.           Deans EI, Grimes DA. Intrauterine devices for adolescents: a systematic review. Contraception 2009; 79(6): 418-23.
21.           McNicholas C, Peipert JF. Long-acting reversible contraception for adolescents. Current opinion in obstetrics & gynecology 2012; 24(5): 293-8.
22.           Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009; 91(5): 1646-53.
23.           Heinemann K, Reed S, Moehner S, Do Minh T. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception 2015.
24.           Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339(8796): 785-8.
25.           Dean G, Goldberg AB. Intrauterine contraception (IUD): Overview. 2014. http://www.uptodate.com/contents/intrauterine-contraception-iud-overview....
26.           ACOG Practice Bulletin No. 112: Emergency contraception. Obstetrics and gynecology 2010; 115(5): 1100-9.
27.           Zieman M. Emergency Contraception. 2014. http://www.uptodate.com/contents/emergency-contraception?source=search_r....
28.           ACOG Committee Opinion Number 542: Access to emergency contraception. Obstetrics and gynecology 2012; 120(5): 1250-3.
29.           Quaas AM, Ginsburg ES. Prevention and treatment of uterine bleeding in hematologic malignancy. European journal of obstetrics, gynecology, and reproductive biology 2007; 134(1): 3-8.
30.           Meirow D, Rabinovici J, Katz D, Or R, Shufaro Y, Ben-Yehuda D. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Cancer 2006; 107(7): 1634-41.
31.           Friedman AJ, Daly M, Juneau-Norcross M, Gleason R, Rein MS, LeBoff M. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years. Human reproduction (Oxford, England) 1994; 9(9): 1618-25.
32.           Divasta AD, Laufer MR, Gordon CM. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis. Journal of pediatric and adolescent gynecology 2007; 20(5): 293-7.
33.           Hubacher D, Lopez L, Steiner MJ, Dorflinger L. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception 2009; 80(2): 113-8.
34.           Committee opinion no. 606: Options for prevention and management of heavy menstrual bleeding in adolescent patients undergoing cancer treatment. Obstetrics and gynecology 2014; 124(2 Pt 1): 397-402.
35.           Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstetrics and gynecology 2003; 101(4): 653-61.